 A STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS MK-3222, FOLLOWED BY AN OPTIONAL LONG-TERM SAFETY EXTENSION STUDY, IN PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC PLAQUE PSORIASIS MK-3222-010: 